Vasorin activators are a diverse set of chemical compounds that enhance the functional activity of Vasorin through various signaling pathways, each with a unique mechanism. Angiotensin II, for instance, directly interacts with the AT1 receptor to upregulate Vasorin expression in vascular smooth muscle cells, contributing to the regulation of vascular tone and remodeling. Similarly, TGF-β1, through its stimulation of TGF-β receptors and subsequent SMAD signaling, increases Vasorin's ability to modulate fibrosis and tissue repair. BMP-4's interaction with BMP receptors and the SMAD1/5/8 signaling cascade is augmented by Vasorin, thereby influencing osteogenesis and vascular homeostasis. Estrogen and Retinoic Acid both employ receptor-mediated gene regulation to elevate Vasorin levels, with implications for vascular protection and cellular development, respectively.
Continuing with the theme of receptor-mediated activation, Wnt3a enhances Vasorin activity by activating the Wnt/β-catenin pathway, which governs cell proliferation and differentiation. Small molecule inhibitors such as PD98059, SB431542, LY294002, and Dorsomorphin indirectly boost Vasorin expressionby altering the dynamics of growth factor signaling, TGF-β signaling, PI3K/AKT signaling, and BMP signaling, respectively. These inhibitors release negative feedback loops or modulate signaling equilibria, leading to enhanced Vasorin activity in processes such as extracellular matrix composition and angiogenesis. A83-01, by inhibiting the TGF-β type I receptor ALK5, and GW9662, as a PPARγ antagonist, also contribute to the increased activity of Vasorin. A83-01's action affects the fibrotic processes and vascular development, whereas GW9662 influences Vasorin's role in adipogenesis and metabolic regulation. Collectively, these activators function through intricate cellular pathways to enhance the activity of Vasorin, each contributing to its comprehensive role in cellular signaling and function without necessitating upregulation at the transcriptional or translational level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $50.00 $75.00 $260.00 $505.00 | 3 | |
Angiotensin II activates the AT1 receptor, which has been shown to upregulate Vasorin expression and promote its functional activity in vascular smooth muscle cells, potentially contributing to vasodilation and vascular remodeling. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol binds to estrogen receptors, which regulate gene expression. Estrogen has been shown to increase Vasorin expression in endothelial cells, suggesting a role in enhancing Vasorin-mediated vascular protection. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid interacts with retinoic acid receptors, influencing cell differentiation. It has been implicated in upregulating Vasorin expression, which may enhance Vasorin's role in cellular development and repair processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor that can lead to an increase in Vasorin expression indirectly by releasing negative feedback loops that control growth factor signaling, thus enhancing Vasorin's regulatory effects on these pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is a TGF-β receptor kinase inhibitor that can increase Vasorin's expression and activity by altering TGF-β signaling dynamics, potentially enhancing Vasorin's role in modulating extracellular matrix composition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that may upregulate Vasorin expression by modifying PI3K/AKT signaling, thereby enhancing Vasorin's involvement in cell survival and angiogenesis. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
Dorsomorphin inhibits BMP signaling and can lead to elevated Vasorin levels, potentially increasing Vasorin's modulatory effects on BMP-mediated vascular and skeletal processes. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
A83-01 is an inhibitor of TGF-β type I receptor ALK5, which can result in increased Vasorin activity by modulating TGF-β signaling, influencing fibrotic processes and vascular development. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $68.00 | 30 | |
GW 9662 is a PPARγ antagonist that can indirectly enhance Vasorin function by affecting PPARγ-mediated gene expression, potentially influencing Vasorin's role in adipogenesis and metabolic regulation. | ||||||